[Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri].
The paper discusses the results of treatment of endometrial cancer patients with high energy radiation (76 cases). Three-year survival rate was 78.3%. A combination of radiation and hormonotherapy was given to 34 cases. The control group (not receiving 17-hydroxyprogesterone caproate treatment) included 42. Survival rate for hormonotherapy group was higher than in controls (84.1 and 74.8%, respectively). Hormonal treatment was the most effective in patients with early stages of cancer and well- and moderately-differentiated tumors.
Bokhman
Ia V
IaV
Stoliarova
I V
IV
Gastev
A Iu
AIu
D000077713:17 alpha-Hydroxyprogesterone Caproate; D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage; D011897:Random Allocation; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy
D006908:Hydroxyprogesterones; D000077713:17 alpha-Hydroxyprogesterone Caproate
Vliianie ad''iuvantnoĭ gormonoterapii na rezul'taty luchevogo lecheniia bol'nykh rakom tela matki.